Life sciences company with large facility in Charles City being sold

East Rutherford, N.J. – One of the nation’s leading drug molecule companies with a location in Northeast Iowa will be acquired by an international investment company.

Cambrex Corporation announced Wednesday it’s signed an greement worth two-point-four billion dollars with a Permira, a private equity firm with offices in London, Tokyo, Hong Kong and New York. 

Cambrex owns a 45-acre sight in Charles City employing 400 people and completed a 24 million dollar expansion in April.

The sale is expected to be completed in the fourth quarter of this year.  


Kellan Heavican

News & Sports Director

Related Articles

Back to top button